News and Announcements
First Graphene Limited (ASX: FGR) announces progress in the development of BEST battery Technology Project
- Published July 12, 2018 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
KEY TAKEAWAY:
- First Graphene Limited (ASX: FGR) announce advancement in the design and installation of equipment and the scaling up of the manufacturing process in the BEST Battery technology project with Swinburne University of Technology.
- The circuitry design has improved to allow the use of 25 lasers simultaneously.
- BEST Battery project confirmed to be at the Technology Readiness Level (TRL) 4.
First Graphene Limited has provided a positive update concerning the progress made by the BEST Battery Supercapacitor project with the Swinburn University of Technology. The Project involves using layers of graphene oxide to create nanopores. The nanopores store electric ions at an energy density level ten times that of existing supercapacitors. The BEST batteries can be recharged with a fraction of the time, having a potential life of at least ten times that of lithium-ion batteries.
First Graphene earns 70% interest in the private company that has an exclusive international licence to the BEST Battery. The project has seen the expansion in the process of circuitry from the use of single lasers to the circuitry design that enables the use of 25 lasers simultaneously. They have also announced the improved mechanical strength, enhanced current collectors of the pouch by vacuum sealing process and Swinburn has advanced the automation process.
First Graphene and the Swinburne University of Technology have used the Technology Readiness Levels (TRL) method to provide an understanding of the technology’s status. The Best Battery Technology project is confirmed to be at the TRL 4 level and is now aiming to continue on toe TRL 5 which included the tested of the technology in the intended environment.
About First Graphene Limited (ASX: FGR)
First Graphene is an advanced materials company seeking to position itself in the lowest cost quartile of global graphene suppliers. It has developed an environmentally sound and safe method of converting its supplies of ultra-high grade graphite into the lowest cost highest quality graphene, in bulk quantities.
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
